The 18 analysts offering 12-month price forecasts for Jazz Pharmaceuticals PLC have a median target of 205.50, with a high estimate of 235.00 and a low estimate of 176.00. The median estimate represents a +15.87% increase from the last price of 177.36.
The current consensus among 17 polled investment analysts is to Buy stock in Jazz Pharmaceuticals PLC. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $3.74
Reporting Date Aug 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.